<SEC-DOCUMENT>0001104659-21-008810.txt : 20210128
<SEC-HEADER>0001104659-21-008810.hdr.sgml : 20210128
<ACCEPTANCE-DATETIME>20210128163158
ACCESSION NUMBER:		0001104659-21-008810
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		15
CONFORMED PERIOD OF REPORT:	20210127
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20210128
DATE AS OF CHANGE:		20210128

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ZYNEX INC
		CENTRAL INDEX KEY:			0000846475
		STANDARD INDUSTRIAL CLASSIFICATION:	ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
		IRS NUMBER:				870403828
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38804
		FILM NUMBER:		21565567

	BUSINESS ADDRESS:	
		STREET 1:		9555 MAROON CIRCLE
		CITY:			ENGLEWOOD
		STATE:			CO
		ZIP:			80112
		BUSINESS PHONE:		(303) 867-3904

	MAIL ADDRESS:	
		STREET 1:		9555 MAROON CIRCLE
		CITY:			ENGLEWOOD
		STATE:			CO
		ZIP:			80112

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ZYNEX MEDICAL HOLDINGS INC
		DATE OF NAME CHANGE:	20050812

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ZYNEX MEDICAL HOLDINGS   INC
		DATE OF NAME CHANGE:	20040120

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	FOX RIVER HOLDINGS  INC
		DATE OF NAME CHANGE:	20031126
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>tm214568d1_8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31" xmlns:us-roles="http://fasb.org/us-roles/2020-01-31" xmlns:country="http://xbrl.sec.gov/country/2020-01-31" xmlns:srt="http://fasb.org/srt/2020-01-31" xmlns:zyxi="http://zynexmed.com/20210127">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
<!-- Field: Set; Name: xdx; ID: xdx_029_US%2DGAAP%2D2020 -->
<!-- Field: Set; Name: xdx; ID: xdx_031_zyxi_zynexmed.com_20210127 -->
<!-- Field: Set; Name: xdx; ID: xdx_040_20210127_20210127 -->
<!-- Field: Set; Name: xdx; ID: xdx_05B_edei%2D%2DEntityCentralIndexKey_0000846475 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
  <ix:hidden>
    <ix:nonNumeric contextRef="From2021-01-27to2021-01-27" name="dei:EntityCentralIndexKey">0000846475</ix:nonNumeric>
    <ix:nonNumeric contextRef="From2021-01-27to2021-01-27" format="ixt:booleanfalse" name="dei:AmendmentFlag">false</ix:nonNumeric>
    </ix:hidden>
  <ix:references>
    <link:schemaRef xlink:href="zyxi-20210127.xsd" xlink:type="simple" />
    </ix:references>
  <ix:resources>
    <xbrli:context id="From2021-01-27to2021-01-27">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000846475</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-27</xbrli:startDate>
        <xbrli:endDate>2021-01-27</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
    </ix:resources>
  </ix:header>
</div>


<p style="margin: 0">&#160;</p>

<p style="margin: 0pt 0"></p>

<!-- Field: Rule-Page --><div style="margin-top: 0; margin-bottom: 0; width: 100%"><div style="border-top: Black 2pt solid; border-bottom: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">UNITED STATES<br />
SECURITIES AND EXCHANGE COMMISSION<br />
Washington, D.C. 20549</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>FORM <span id="xdx_90E_edei--DocumentType_c20210127__20210127_zIilnujq5as2"><ix:nonNumeric contextRef="From2021-01-27to2021-01-27" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">CURRENT REPORT</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Date of Report (Date of earliest event reported): <span id="xdx_900_edei--DocumentPeriodEndDate_c20210127__20210127_zWNDsRDJxKGe"><ix:nonNumeric contextRef="From2021-01-27to2021-01-27" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate">January 27, 2021</ix:nonNumeric></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><span id="xdx_900_edei--EntityRegistrantName_c20210127__20210127_zIHdESaepU9a" style="text-transform: uppercase"><b><span style="text-decoration: underline"><ix:nonNumeric contextRef="From2021-01-27to2021-01-27" name="dei:EntityRegistrantName">Zynex,
Inc.</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Exact name of registrant as specified in
its charter)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="text-decoration: underline; width: 37%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="text-decoration: underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="text-decoration: underline"><span id="xdx_90F_edei--EntityIncorporationStateCountryCode_c20210127__20210127_zQR6kFXIfCGa"><ix:nonNumeric contextRef="From2021-01-27to2021-01-27" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode">Nevada</ix:nonNumeric></span></span><span style="text-decoration: underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></td>
    <td style="text-decoration: underline; width: 28%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="text-decoration: underline"><span id="xdx_90C_edei--EntityFileNumber_c20210127__20210127_zv7fVBXGSwm6"><ix:nonNumeric contextRef="From2021-01-27to2021-01-27" name="dei:EntityFileNumber">001-38804</ix:nonNumeric></span></span></td>
    <td style="text-decoration: underline; width: 35%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="text-decoration: underline"><span id="xdx_90C_edei--EntityTaxIdentificationNumber_c20210127__20210127_zr4j5ZqtCdJh"><ix:nonNumeric contextRef="From2021-01-27to2021-01-27" name="dei:EntityTaxIdentificationNumber">90-0275169</ix:nonNumeric></span></span></td></tr>
<tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">(State or other jurisdiction<br />
&#160;of incorporation)</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">Commission File<br />
Number</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">
        <p style="margin-top: 0pt; margin-bottom: 0pt">(IRS Employer Identification</p>
        <p style="margin-top: 0pt; margin-bottom: 0pt">No.)</p></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="text-decoration: underline"><span id="xdx_909_edei--EntityAddressAddressLine1_c20210127__20210127_zo9gxenDKJ1"><ix:nonNumeric contextRef="From2021-01-27to2021-01-27" name="dei:EntityAddressAddressLine1">9555 Maroon Circle</ix:nonNumeric></span>, <span id="xdx_906_edei--EntityAddressCityOrTown_c20210127__20210127_zYXQTdBpPCGi"><ix:nonNumeric contextRef="From2021-01-27to2021-01-27" name="dei:EntityAddressCityOrTown">Englewood</ix:nonNumeric></span>, <span id="xdx_902_edei--EntityAddressStateOrProvince_c20210127__20210127_zkPjS3GkuOw9"><ix:nonNumeric contextRef="From2021-01-27to2021-01-27" name="dei:EntityAddressStateOrProvince">CO</ix:nonNumeric></span> <span id="xdx_905_edei--EntityAddressPostalZipCode_c20210127__20210127_z0lfXbIHSZt7"><ix:nonNumeric contextRef="From2021-01-27to2021-01-27" name="dei:EntityAddressPostalZipCode">80112</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">(Address of principal
executive offices)&#160;&#160;(Zip Code)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Registrant's telephone number, including area code:&#160; <span style="text-decoration: underline">(<span id="xdx_907_edei--CityAreaCode_c20210127__20210127_zpeMlheTlLNb"><ix:nonNumeric contextRef="From2021-01-27to2021-01-27" name="dei:CityAreaCode">303</ix:nonNumeric></span>) <span id="xdx_906_edei--LocalPhoneNumber_c20210127__20210127_zpH3ox314AVb"><ix:nonNumeric contextRef="From2021-01-27to2021-01-27" name="dei:LocalPhoneNumber">703-4906</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Check the appropriate box below if the
Form&#160;8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions
(see General Instruction A.2. below):</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
<tr style="vertical-align: top; text-align: justify">
    <td style="width: 0in"></td>
    <td style="width: 0.5in; text-align: left"><span style="font-family: Wingdings"><span style="font-family: Wingdings"><span id="xdx_90C_edei--WrittenCommunications_c20210127__20210127_zOa5EpO7bHW5"><ix:nonNumeric contextRef="From2021-01-27to2021-01-27" format="ixt:booleanfalse" name="dei:WrittenCommunications">&#168;</ix:nonNumeric></span></span></span></td>
    <td style="text-align: justify">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
<tr style="vertical-align: top; text-align: justify">
    <td style="width: 0in"></td>
    <td style="width: 0.5in; text-align: left"><span style="font-family: Wingdings"><span id="xdx_900_edei--SolicitingMaterial_c20210127__20210127_z1XWUUFwh9Mf"><ix:nonNumeric contextRef="From2021-01-27to2021-01-27" format="ixt:booleanfalse" name="dei:SolicitingMaterial">&#168;</ix:nonNumeric></span></span></td>
    <td style="text-align: justify">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
<tr style="vertical-align: top; text-align: justify">
    <td style="width: 0in"></td>
    <td style="width: 0.5in; text-align: left"><span style="font-family: Wingdings"><span id="xdx_909_edei--PreCommencementTenderOffer_c20210127__20210127_z9qZx8zVC3Kj"><ix:nonNumeric contextRef="From2021-01-27to2021-01-27" format="ixt:booleanfalse" name="dei:PreCommencementTenderOffer">&#168;</ix:nonNumeric></span></span><span style="font-family: Wingdings"></span></td>
    <td style="text-align: justify">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
<tr style="vertical-align: top; text-align: justify">
    <td style="width: 0in"></td>
    <td style="width: 0.5in; text-align: left"><span style="font-family: Wingdings"><span id="xdx_906_edei--PreCommencementIssuerTenderOffer_c20210127__20210127_zBlt2fJgGqrg"><ix:nonNumeric contextRef="From2021-01-27to2021-01-27" format="ixt:booleanfalse" name="dei:PreCommencementIssuerTenderOffer">&#168;</ix:nonNumeric></span></span><span style="font-family: Wingdings"></span></td>
    <td style="text-align: justify">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Securities registered pursuant to Section
12(b) of the Act:</p>



<p style="margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding: 1.5pt; width: 38%; text-align: center">Title of each class</td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding: 1.5pt; width: 26%; text-align: center">Ticker symbol(s)</td>
    <td style="border-top: Black 1pt solid; border-right: black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding: 1.5pt; width: 36%; text-align: center">Name of each exchange on which <br />
registered</td></tr>
<tr style="vertical-align: bottom">
    <td style="border-bottom: black 1pt solid; border-left: black 1pt solid; padding: 1.5pt; text-align: center"><span id="xdx_909_edei--Security12bTitle_c20210127__20210127_zr0EjQwcjgGg"><ix:nonNumeric contextRef="From2021-01-27to2021-01-27" name="dei:Security12bTitle">Common Stock, $0.001 par value per share</ix:nonNumeric></span></td>
    <td style="border-bottom: black 1pt solid; border-left: black 1pt solid; padding: 1.5pt; text-align: center"><span id="xdx_904_edei--TradingSymbol_c20210127__20210127_zzGTMimsmCZh"><ix:nonNumeric contextRef="From2021-01-27to2021-01-27" name="dei:TradingSymbol">ZYXI</ix:nonNumeric></span></td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding: 1.5pt; text-align: center">The <span id="xdx_908_edei--SecurityExchangeName_c20210127__20210127_znU3H6aVsCZ9"><ix:nonNumeric contextRef="From2021-01-27to2021-01-27" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">Nasdaq</ix:nonNumeric></span> Capital Market</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Indicate by check mark whether the registrant
is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405) or Rule 12b-2
of the Securities Exchange Act of 1934 (&#167;240.12b-2).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Emerging growth company <span style="font-family: Wingdings"><span id="xdx_904_edei--EntityEmergingGrowthCompany_c20210127__20210127_z2McjTQMt6y3"><ix:nonNumeric contextRef="From2021-01-27to2021-01-27" format="ixt:booleanfalse" name="dei:EntityEmergingGrowthCompany">&#168;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">If an emerging growth company, indicate
by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial
accounting standards provided pursuant to Section 13(a) of the Exchange Act. <span style="font-family: Wingdings">&#168;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Rule-Page --><div style="margin-top: 0; margin-bottom: 0; width: 100%"><div style="border-top: Black 1pt solid; border-bottom: Black 2pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 1in"><b>Item 5.02</b></td><td><b>Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements
of Certain Officers.</b></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Appointment of Anna Lucsok as Chief
Operating Officer of Zynex Medical,&#160;Inc. and departure of Chief Operating Officer, Giuseppe Papandrea.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Effective January&#160;27, 2021, Giuseppe Papandrea resigned
as Chief Operating Officer of Zynex Medical,&#160;Inc. (&#8220;Company&#8221;), which was not as a result of any disagreements
with the Company or its management.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Effective January&#160;27, 2021, the Board of Directors promoted
Anna Lucsok, Vice President of Reimbursement to Chief Operating Officer and entered into an employment agreement with Ms.&#160;Lucsok.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Since October&#160;2019, Ms.&#160;Lucsok served as Vice President
of Reimbursement and Sales Operations with Zynex Medical. From February&#160;2018 to October&#160;2019, Ms.&#160;Lucsok served
as Zynex Medical&#8217;s Billing Manager. Prior to joining Zynex Medical, from October&#160;2017 to February&#160;2018, she worked
in billing and business support for University of Colorado Hospital, and from November&#160;2014 to October&#160;2017, she served
the U.S. Air Force mission support in Germany and Japan. In her position as the Vice President of Reimbursement and Sales Operations
she was responsible for leading and expanding Zynex&#8217;s order, reimbursement, patient experience, and inside sales support
operations. During her tenure each of these teams have consistently achieved quarterly targets, while also expanding in size. Ms.&#160;Lucsok
brings more than 9 years of healthcare operations experience as well as critical knowledge of revenue cycle management and medical
care collections. Ms.&#160;Lucsok holds certification in medical billing as well as completed her degree in Healthcare Administration
and Management from Colorado State University.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">There is no arrangement or understanding
between Ms.&#160;Lucsok and any other person pursuant to which she was selected as an officer of the Company. There is no family
relationship between Ms.&#160;Lucsok and any director or executive officer of the Company, and Ms.&#160;Lucsok is not a party to
a related party transaction within the meaning of Item 404(a)&#160;of Regulation S-K.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Ms.&#160;Lucsok has a Degree in Healthcare Administration and
Management from Colorado State University.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Pursuant to the employment agreement, the
Company and Ms.&#160;Lucsok agreed to the following:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 48px">&#160;</td>
    <td style="width: 48px; font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#8226;</span></td>
    <td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">Ms.&#160;Lucsok will receive annual base salary of $200,000 and be eligible for annual incentive compensation of up to $200,000 in cash and up to $100,000 of restricted shares, based upon achievement of annual incentive compensation targets established by the Company&#8217;s Board of Directors.</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 48px">&#160;</td>
    <td style="width: 48px; font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#8226;</span></td>
    <td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">The Company awarded Ms.&#160;Lucsok an initial grant of 50,000 restricted shares, vesting annually over a four-year period.</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 48px">&#160;</td>
    <td style="width: 48px; font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#8226;</span></td>
    <td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">Ms.&#160;Lucsok will also be eligible to receive quarterly grants equal to 5,000 shares of restricted stock, vesting annually over a four-year period.</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 48px">&#160;</td>
    <td style="width: 48px; font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#8226;</span></td>
    <td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">Ms.&#160;Lucsok will be employed &#8220;at will.&#8221;</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 48px">&#160;</td>
    <td style="width: 48px; font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#8226;</span></td>
    <td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">If the Company terminates Ms.&#160;Lucsok&#8217;s employment for reasons other than cause or disability, or Ms.&#160;Lucsok resigns for &#8220;Good Reason,&#8221; as such terms are defined in her employment agreement, the Company will pay Ms.&#160;Lucsok severance equal to six months of her base salary. The Company will also pay a proportionate amount of Ms.&#160;Lucsok&#8217;s health and dental insurance premiums, based upon the same proportion the Company paid at the time Ms.&#160;Lucsok&#8217;s employment was terminated, for the applicable severance period or until Ms.&#160;Lucsok obtains substitute insurance. Severance and insurance premium payments will be made in equal installments over the applicable 6-month period, based upon the Company&#8217;s normal payroll practices.</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 48px">&#160;</td>
    <td style="width: 48px; font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#8226;</span></td>
    <td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">Ms.&#160;Lucsok agreed that following termination of employment she will not compete with the Company (as defined in the employment agreement), or solicit or entice any employee of the Company to leave the employ of the Company or interfere with the Company&#8217;s relationship with a customer during the period of time that severance is paid.</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The full text of the employment agreement
is attached as Exhibit&#160;10.1 to the Current Report on Form&#160;8 K and is qualified in its entirety thereby.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 1in"><b>ITEM 9.01</b></td><td><b>FINANCIAL STATEMENTS AND EXHIBITS</b></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="text-decoration: underline">Exhibits</span>.
The following exhibits are filed with this report.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="border: Black 1pt solid; width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Exhibit&#160;No.</b></span></td>
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; width: 86%; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Description</b></span></td></tr>
<tr style="vertical-align: top">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt"><a href="tm214568d1_ex10-1.htm"><span style="font: 10pt Times New Roman, Times, Serif">10.1</span></a></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt"><a href="tm214568d1_ex10-1.htm"><span style="font: 10pt Times New Roman, Times, Serif">Employment Agreement effective January&#160;27, 2021, entered into between Zynex Medical,&#160;Inc. and Anna Lucsok</span></a></td></tr>
<tr style="vertical-align: top">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt"><a href="tm214568d1_ex99-1.htm"><span style="font: 10pt Times New Roman, Times, Serif">99.1</span></a></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt"><a href="tm214568d1_ex99-1.htm"><span style="font: 10pt Times New Roman, Times, Serif">Press Release</span></a></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SIGNATURES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Pursuant to the requirements of the Securities Exchange Act
of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td colspan="2" style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>ZYNEX,&#160;INC.</b></span></td></tr>
<tr style="vertical-align: top">
    <td style="width: 6%; text-align: justify">&#160;</td>
    <td style="width: 43%; text-align: justify">&#160;</td>
    <td style="width: 3%; text-align: justify">&#160;</td>
    <td style="width: 48%; text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Dated: January&#160;28, 2021&#160;</span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="border-bottom: Black 1pt solid">
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">/s/ <i>Daniel Moorhead</i></p></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td>Daniel Moorhead</td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td>Chief Financial Officer</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 3; Options: Last -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

</body>
</html>
<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjUEKwkAMRU/QO4RZi06rddGdFhWxipQibgcbZbCdlMxY9Uje0mmLGAIh+f/lCzESG1rrChnOyzyDAuumUg4hxysymgt6R7rdJeBnjjdtHSvj+vUHpuQZ9Ew8nl78vXe22mKZgJxP5GwSSQjDJI5gsRdBp6dkrrpE47SqQJkSjkwNa3SK38OHQr3IUP3uk07IVpNJIBzLQf5AJMMIDtSqJ/HdQpalIhj1FYgN06PpYh7WUQ2rCmufZQf038EX04pJBw== -->
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>tm214568d1_ex10-1.htm
<DESCRIPTION>EXHIBIT 10.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit&nbsp;10.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; color: Red">&nbsp;<IMG SRC="tm214568d1_ex10-1img01.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; color: Red"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>EMPLOYMENT AGREEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This <FONT STYLE="font-variant: small-caps"><B>Employment
Agreement</B></FONT> (this &ldquo;<B><I>Agreement</I></B>&rdquo;) is entered into effective January&nbsp;27, 2021 (the &ldquo;<B><I>Effective
Date</I></B>&rdquo;), by <FONT STYLE="font-variant: small-caps"><B>Anna Lucsok</B></FONT> (&ldquo;<B><I>Executive</I></B>&rdquo;)
and Zynex Medical (the &ldquo;<B><I>Company</I></B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>RECITALS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">A.</TD><TD STYLE="text-align: justify">Company desires to hire Executive as Chief Operating Officer and to compensate Executive for Executive&rsquo;s
services to the Company; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">B.</TD><TD STYLE="text-align: justify">Executive wishes to be employed by the Company and provide services to the Company in return for
certain compensation; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt">C.</FONT></TD><TD STYLE="text-align: justify">WHEREAS, the Company and Executive desire to enter into this Agreement</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Accordingly, in consideration of the mutual
promises and covenants contained in this Agreement and for other good and valuable consideration, the sufficiency of which is acknowledged,
the parties agree to the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>1.</B></FONT><B><FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-variant: small-caps"><U>Definitions</U></FONT></B><B><FONT STYLE="font-family: Times New Roman, Times, Serif">.</FONT></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt"><B>1.1</B></FONT></TD><TD STYLE="text-align: justify">&ldquo;<B><I>Affiliates&rdquo; </I></B>means, with respect to the Company, any entity which, directly
or indirectly, is controlled by or is under common control with the Company</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt"><B>1.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT>&ldquo;<B><I>Board
of Directors</I></B>&rdquo; or &ldquo;<B><I>Board</I></B>&rdquo; means the Board of Directors of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt"><B>1.3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT>&ldquo;<B><I>Cause</I></B>&rdquo;
will be limited to mean the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt"><B>(i)</B></FONT></TD><TD STYLE="text-align: justify">Willful misfeasance or nonfeasance by Executive that materially injures the reputation, business
or business relationships of the Company or its Affiliates, or any of their respective officers, directors or employees and such
action or failure is not remedied or reasonable steps to effect such remedy are not commenced within thirty (30) days following
receipt of written notice;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt"><B>(ii)</B></FONT></TD><TD STYLE="text-align: justify">Any act involving moral turpitude or conviction of a crime other reflects in some material fashion
unfavorably upon the business or business relationships of the Company, its Affiliates, or any of its officers, directors or employees;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt"><B>(iii)</B></FONT></TD><TD STYLE="text-align: justify">The willful and continued failure to perform substantially the Executive&rsquo;s duties or to follow
the reasonable direction of the CEO or the Board within thirty (30) business days after receipt by Executive of written notice
of such failure, other than by reason of Disability (as defined below) or approved leave of absence; or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt"><B>(iv)</B></FONT></TD><TD STYLE="text-align: justify">Willful or prolonged absence from work by Executive, other than by reason of Disability or approved
leave of absence, whether paid or unpaid.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt"><B>1.4</B></FONT></TD><TD STYLE="text-align: justify"><I>&ldquo;<B>Code</B>&rdquo; </I>will mean the Internal Revenue Code of 1986, as amended from time
to time, and the regulations promulgated thereunder.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt"><B>1.5</B></FONT></TD><TD STYLE="text-align: justify"><I>&ldquo;<B>Disability</B></I>&rdquo; will mean the earliest of the date on which Executive is
deemed disabled under: (i)&nbsp;the long-term disability policy maintained by the Company; (ii)&nbsp;Code Section&nbsp;22(e)(3);
or (iii)&nbsp;the determination of the Social Security Administration. Notwithstanding the foregoing, Executive will not be considered
to have suffered a Disability under subparagraph (ii)&nbsp;above if Executive timely provides medical certification from a qualified
licensed physician that Executive is able to perform the essential functions of Executive&rsquo;s position, with or without reasonable
accommodation.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt"><B>1.6</B></FONT></TD><TD STYLE="text-align: justify">&ldquo;<B><I>Good Reason</I></B>&rdquo; will mean the occurrence of any of the following without
Executive&rsquo;s prior written consent:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt"><B>(i)</B></FONT></TD><TD STYLE="text-align: justify">the removal of Executive as Chief Operating Officer of the Company, assignment to Executive of
any duties or responsibilities materially inconsistent with Executive&rsquo;s position, including any material diminution of Executive&rsquo;s
status, title, authority, duties or responsibilities or any other action that results in a material diminution in such status,
title, authority, duties or responsibilities;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt"><B>(ii)</B></FONT></TD><TD STYLE="text-align: justify">the reduction by five percent (5%) or more of Executive&rsquo;s base salary or the reduction by
five percent (5%) or more of the aggregate of Executive&rsquo;s base salary and Incentive Compensation target cumulatively during
any one year period, without Executive&rsquo;s consent, or any action that materially adversely affects Executive&rsquo;s overall
compensation and benefits package, provided that the Company may change the benefits package if those changes are made on a non-discriminatory
basis for all employees who participate in the benefits plans available to Executive; or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt"><B>(iii)</B></FONT></TD><TD STYLE="text-align: justify">the failure of the Company to pay to Executive any portion or installment of any salary,&nbsp;Incentive
Compensation or deferred compensation within fifteen (15) days of the date such compensation is due.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt"><B>1.7</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><B>&ldquo;<I>Termination Date</I>&rdquo; </B></FONT>will mean Executive&rsquo;s
last day of employment, regardless of whether termination is on account of death, Disability, with or without Cause, or a resignation
with or without Good Reason.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B>2.</B></FONT><B><FONT STYLE="font-size: 10pt; font-variant: small-caps">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></B><B><FONT STYLE="font-family: Times New Roman, Times, Serif; font-variant: small-caps"><U>Employment
by the Company</U>.</FONT></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt"><B>2.1</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-variant: small-caps"><B><U>Position</U></B></FONT>. Subject to the terms set
forth in this Agreement, the Company agrees to employ Executive in the position of Chief Operating Officer and Executive hereby
accepts such employment and position. During the term of Executive&rsquo;s employment with the Company, Executive will devote Executive&rsquo;s
best efforts and substantially all of Executive&rsquo;s business time and attention to the business of the Company.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt"><B>2.2</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-variant: small-caps"><B><U>Duties</U></B></FONT>. Executive will report to the
CEO and will perform such duties as are normally associated with Executive&rsquo;s position as are assigned to Executive from time
to time. Executive will perform Executive&rsquo;s duties under this Agreement at the Company&rsquo;s principal place of business
and such other locations as agreed upon by Executive and the Company.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt"><B>2.3</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-variant: small-caps"><B><U>Term</U></B>. </FONT>The term of this Agreement will
run from the Effective Date until such time as it is terminated in accordance with the terms of this Agreement.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt"><B>2.4</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-variant: small-caps"><B><U>Company Policies and Benefits</U></B></FONT>. The
employment relationship between the parties will be subject to the Company&rsquo;s personnel policies and procedures as they may
be adopted, revised or deleted from time to time in the Company&rsquo;s sole discretion. Subject to any specific exceptions or
conditions set forth in <U>Section&nbsp;3.5</U>, Executive will be eligible to participate on substantially the same basis as similarly
situated Executives in the Company&rsquo;s benefit plans and programs in effect from time to time during Executive&rsquo;s employment;
<I>provided, however</I>, that participation and awards under any equity compensation or equity Incentive Compensation plan or
program will be determined by the Board on an individual, case-by-case basis. All matters of eligibility for coverage or benefits
under any benefit plan or program will be determined in accordance with the provisions of such plan or program. The Company reserves
the right to change, alter, or terminate any benefit plan or program in its sole discretion; <I>provided</I>, <I>however</I>, that
no such change, alteration or termination will change any vested or accrued benefits or rights of Executive. Notwithstanding the
foregoing, in the event that the terms of this Agreement expressly provide Executive with benefits that differ from the Company&rsquo;s
generally available benefits, then the terms of this Agreement will control.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt; font-variant: small-caps"><B><U>Compensation
and Benefits</U></B></FONT>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt"><B>2.5</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-variant: small-caps"><B><U>Salary</U></B></FONT>. Executive will receive for
Executive&rsquo;s services to be rendered under this Agreement an initial annualized base salary of $200,000 (the &ldquo;<B><I>Base
Salary</I></B>&rdquo;), subject to annual review and adjustment from time to time by the CEO. The Base Salary will be payable in
accordance with Company&rsquo;s standard payroll practices.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt"><B>2.6</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-variant: small-caps"><B><U>Stock Grants</U></B></FONT>. Executive will receive
50,000 restricted shares on the date this agreement is executed. These shares vest over four years, at a rate of 25% per year.
Executive will also receive ongoing quarterly grants of 5,000 restricted shares that also vest over four years, at a rate of 25%
per year.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt"><B>2.7</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-variant: small-caps"><B><U>Incentive Compensation</U></B></FONT>. Executive will
be eligible for quarterly incentive compensation (&ldquo;<B><I>Incentive Compensation</I></B>&rdquo;) in the total amount of <B>$200,000
</B>per calendar year, as determined by the CEO based on an incentive compensation plan to be established annually in writing by
the Board. The Incentive Compensation will be calculated based on performance goals measured at the end of the applicable quarter.
The Company will pay earned quarterly Incentive Compensation at the time(s)&nbsp;determined by the Company, but in no event later
than 15 days after when the Company&rsquo;s financial results are published following the quarter in which Executive&rsquo;s right
to the Incentive Compensation arises. In addition to the cash incentive compensation, Executive will be eligible to earn restricted
stock on a quarterly basis up to a value of $100,000 per year, based on the same performance metrics.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt"><B>2.8</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-variant: small-caps"><B><U>Expense Reimbursement</U></B></FONT>. The Company
will reimburse Executive for reasonable business expenses incurred by Executive during the period Executive is employed by the
Company, in accordance with the Company&rsquo;s standard expense reimbursement policy.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt"><B>2.9</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-variant: small-caps"><B><U>Paid Time Off.</U></B></FONT> Executive will have
paid time off in accordance with Company policy.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt"><B>2.10</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-variant: small-caps"><B><U>Benefits </U></B></FONT> As provided in <U>Section&nbsp;2.4</U>,
Executive will receive benefits in accordance with the Company&rsquo;s standard benefits plan and policies, as amended from time
to time.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt"><B>3.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-variant: small-caps"><B><U>Non-Competition; Non-Solicitation; Confidentiality</U>.</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt"><B>3.1</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-variant: small-caps"><B><U>Non-Competition</U></B></FONT>. Executive acknowledges
that Executive will gain extensive and valuable experiences and knowledge in the business conducted by the Company and its Affiliates
and will have extensive contacts with customers of the Company and its Affiliates. Accordingly, in consideration of the mutual
promises contained in this Agreement, Executive covenants and agrees with the Company that, during the term of this Agreement and
for the Applicable Severance Payout Period (as defined in Section&nbsp;7.2(c)&nbsp;following the Executive&rsquo;s Termination
Date, Executive will not compete directly or indirectly with the Company or its Affiliates and will not during such period make
public statements in derogation of the Company or its Affiliates. Competing directly or indirectly with the Company and its Affiliates
will mean engaging or having a material interest, directly or indirectly, as owner, employee, officer, director, partner, venturer,
stockholder, capital investor, consultant, agent, principal, advisor or otherwise, either alone or in association with others,
in the operation of any entity&rsquo;s division or group which manufactures and markets medical devices that treat chronic and
acute pain, as well as activate and exercise muscles for rehabilitative purposes with electrical stimulation. Competing directly
or indirectly with the Company or its Affiliates, as used in this Agreement, will not include having an ownership interest as an
inactive investor, which for purposes of this Agreement will mean the beneficial ownership of less than five percent (5%) of the
outstanding shares of any series or class of securities of any competitor of the Company, which shares are publicly traded in the
securities markets. This <U>Section&nbsp;4.1</U> will cease to apply in the event the Company is in breach of any obligations to
provide severance benefits in accordance with <U>Section&nbsp;7.2</U> and fails to cure such breach within twenty (20) days of
receiving written notice of such breach from Executive. Executive agrees that any violation of this <U>Section&nbsp;4.1</U> by
Executive, as determined by a court of law, will result in termination of the Company&rsquo;s obligations to provide severance
benefits under this Agreement and in the event of such termination, Executive will be required to repay to the Company any such
severance benefits previously received.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt"><B>3.2</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-variant: small-caps"><B><U>Non-Solicitation</U></B></FONT><B>. </B>Executive
acknowledges that Executive will have extensive contacts with employees and customers of the Company. Accordingly, in consideration
of the mutual promises contained in this Agreement, Executive covenants and agrees that during the term of this Agreement, and
for the Applicable Severance Payout Period following Executive&rsquo;s Termination Date, Executive will not (i)&nbsp;solicit, raid,
entice or induce any employee of the Company or its Affiliates to leave the employ of the Company or its Affiliates; (ii)&nbsp;interfere
with the relationship of the Company or its Affiliates with any such employees, including, but not limited to, hiring such employee;
or (iii)&nbsp;personally target or solicit customers of the Company or its Affiliates to purchase products or services in competition
with the Company&rsquo;s or its Affiliates products or services or to terminate a relationship with the Company or its Affiliates.
This <U>Section&nbsp;4.2</U> will cease to apply in the event the Company is in breach of any obligations to provide severance
benefits in accordance with <U>Section&nbsp;7.2</U> and fails to cure such breach within twenty (20) days of receiving notice of
such breach from Executive. Executive agrees that any violation of this <U>Section&nbsp;4.2</U> by Executive, as determined by
a court of law, will result in termination of the Company&rsquo;s obligations to provide severance benefits hereunder and in the
event of such termination, Executive will be required to repay to the Company any such severance benefits previously received.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt"><B>3.3</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-variant: small-caps"><B><U>Confidentiality</U></B></FONT><B>.</B> Executive acknowledges
that Executive will have access to certain information related to the business, operations, future plans and customers of the Company
and its Affiliates, the disclosure or use of which could cause the Company substantial losses and damages. Accordingly, Executive
acknowledges and affirms the terms and conditions of the Confidentiality and Non-Compete Agreement signed by Executive, which is
incorporated by reference. The terms and conditions of Sections 4.1 and 4.2 will take precedence over any non-competition/non-solicitation
provisions contained in the Confidentiality and Non-Compete Agreement.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt"><B>4.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-variant: small-caps"><B><U>Outside Activities</U></B>.</FONT> Except with the
prior written consent of the CEO, Executive will not, while employed by the Company, undertake or engage in any other employment,
occupation, consulting, advisory, or other business enterprise or business activities that would interfere with Executive&rsquo;s
responsibilities and the performance of Executive&rsquo;s duties under this Agreement with the exception that engaging in charitable,
civic, community activities and serving of boards of directors of charitable or civic organizations will not constitute interference,
provided the time spent in such activities does not negatively impact Executive&rsquo;s performance of Executive&rsquo;s duties
under this Agreement.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt"><B>5.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-variant: small-caps"><B><U>No Conflict with Existing Obligations</U></B></FONT>.
Executive represents that Executive&rsquo;s performance of all the terms of this Agreement and as an executive of the Company does
not and will not breach any agreement or obligation of any kind made prior to Executive&rsquo;s employment by the Company, including
agreements or obligations Executive may have with prior employers or entities for which Executive has provided services. Executive
has not entered into, and Executive agrees that Executive will not enter into, any agreement or obligation, either written or oral,
that conflicts with Executive&rsquo;s obligations hereunder.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt; font-variant: small-caps"><B>6.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-variant: small-caps"><B><U>Termination of Employment</U></B></FONT>. The parties
acknowledge that Executive&rsquo;s employment relationship with the Company is at-will. Either Executive or the Company may terminate
the employment relationship at any time, with or without Cause. The provisions in this <U>Section&nbsp;7</U> govern the amount
of compensation, if any, to be provided to Executive upon termination of Executive&rsquo;s employment and do not alter Executive&rsquo;s
at-will status.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt"><B>6.1</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-variant: small-caps"><B><U>Standard Termination Payments</U></B></FONT>.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt"><B>a.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><B><U>Salary and Reimbursements</U></B></FONT>. Regardless of the
reason for termination, the Company will pay Executive on the first regularly scheduled payroll date following Executive&rsquo;s
Termination Date any Base Salary accrued but unpaid as of Executive&rsquo;s Termination Date, the value of any accrued paid time
off unused by Executive as of Executive&rsquo;s Termination Date, and any unpaid Expense Reimbursement, so long as the Expense
Reimbursement complies with the Company guidelines for such requests.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt"><B>b.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><B><U>Incentive Compensation</U></B></FONT>. In the event Executive&rsquo;s
employment with the Company terminates for any reason (including death or Disability) before the end of any quarterly or annual
performance period on which the Incentive Compensation is based, Executive will be paid a pro-rata portion of Executive&rsquo;s
Incentive Compensation (based on the number of days Executive was employed in the applicable quarter with regard to the quarterly
Incentive Compensation and the number of days Executive was employed in the calendar year with respect to the annual Incentive
Compensation) of the Incentive Compensation that is earned for the quarter/year in which Executive&rsquo;s employment with the
Company terminated, such amounts to be paid on the date the Company would otherwise have paid the Incentive Compensation if Executive&rsquo;s
employment with the Company had not terminated. If the Incentive Compensation is considered &ldquo;compensation&rdquo; for purposes
of any Company-sponsored qualified retirement plan, the right to defer such Incentive Compensation will continue to be governed
by such plan or plans, with the terms of such plan or plans incorporated into this Agreement by reference.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt"><B>6.2</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-variant: small-caps"><B><U>Severance Benefits &horbar; Termination Without Cause/Resignation
For Good Reason</U></B></FONT>.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt"><B>a.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><B><U>Company&rsquo;s Right to Terminate</U></B></FONT>. The Company
will have the right to terminate Executive&rsquo;s employment under this Agreement for any of the following reasons:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(i)</B></FONT><B><FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></B><FONT STYLE="font-family: Times New Roman, Times, Serif">upon
Executive&rsquo;s Disability in accordance with <U>Section&nbsp;7.5</U>;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(ii)</B></FONT><B><FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></B><FONT STYLE="font-family: Times New Roman, Times, Serif">for
Cause, by giving notice as described in <U>Section&nbsp;7.6</U>;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(iii)</B></FONT><B><FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></B><FONT STYLE="font-family: Times New Roman, Times, Serif">without
Cause.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 31.5pt"><FONT STYLE="font-size: 10pt"><B>b.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><B><U>Executive&rsquo;s Right to Terminate</U></B></FONT>. Executive
will have the right to resign Executive&rsquo;s employment with the Company at any time, as well as following an event constituting
Good Reason.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 31.5pt"><FONT STYLE="font-size: 10pt"><B>c.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><B><U>Severance Benefits</U></B></FONT>. In the event that the Company
terminates Executive&rsquo;s employment without Cause or Executive resigns for Good Reason, Executive will receive, in addition
to the Standard Termination Payments, the following:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt"><B>(i)</B></FONT></TD><TD STYLE="text-align: justify"><B><U>Severance Payments</U></B>. Provided that Executive delivers to the Company a fully executed
and complete release, without revocation, in favor of the Company and its Affiliates, and in form and substance satisfactory to
the Company (the <B><I>&ldquo;Release&rdquo;</I></B>) within thirty (30) days of Executive&rsquo;s Termination Date (the <B><I>&ldquo;Execution
Deadline&rdquo;</I></B>), the Company will provide to Executive (a)&nbsp; an amount equal to six (6)&nbsp;months of Executive&rsquo;s
then-current Base Salary. The Severance Payments will be payable in equal installment payments over the <B>six (6)&nbsp;month period
</B>(<B>&ldquo;Applicable Severance Payout Period&rdquo;</B>) starting retroactively from the Termination Date in accordance with
the Company&rsquo;s regular bi-weekly paydays, or if different, in accordance with the Company&rsquo;s customary payroll practices.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt"><B>(ii)</B></FONT></TD><TD STYLE="text-align: justify"><B><U>COBRA Benefits</U></B>. In the event Executive elects continuation coverage pursuant to the
Consolidated Omnibus Budget Reconciliation Act of 1985 (&ldquo;COBRA&rdquo;) in accordance with the COBRA materials that will be
provided to Executive by the Company or the Company&rsquo;s third party COBRA administrator, the Company will pay the Company&rsquo;s
portion (based upon the Company&rsquo;s monthly premium subsidy immediately prior to the Termination Date) of Executive&rsquo;s
COBRA premium for the same medical, dental and vision benefit plan coverage (&ldquo;<B><I>Group Health Plan Coverage</I></B>&rdquo;)
Executive and Executive&rsquo;s dependents had as of the Termination Date for the Applicable Severance Payout Period, or until
Executive elects to receive group medical, dental and vision insurance from another source, whichever occurs first. Payment of
COBRA premiums will be made by the Company on Executive&rsquo;s behalf directly to the Group Health Plan&rsquo;s COBRA administrator.
Executive will be mailed a COBRA packet at his last known address. Such packet will contain additional information about Executive&rsquo;s
COBRA rights and responsibilities.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt"><B>(iii)</B></FONT></TD><TD STYLE="text-align: justify"><B><U>Severance Benefits Contingent on Execution of Release</U></B>. Notwithstanding the foregoing,
any Severance Payments that are otherwise payable before the Execution Deadline will be withheld pending Executive&rsquo;s execution
and delivery of the Release and will be paid on the payroll date immediately following the Execution Deadline. For the avoidance
of doubt, Executive will forfeit the right to receive any Severance Payments or COBRA Benefits if Executive fails to deliver the
Release by the Execution Deadline. For this forfeiture to take effect, the Release will not materially alter Executive&rsquo;s
rights to receive any payments or benefits under this Agreement; enlarge Executive&rsquo;s obligations under this Agreement, including
without limitation, Executive&rsquo;s covenants of non-competition and non-solicitation; or impose material new obligations on
Executive.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 31.5pt"><FONT STYLE="font-size: 10pt"><B>d.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><B><U>Compliance with Code Section&nbsp;409A</U></B></FONT>. The
Company and Executive intend that (i)&nbsp;payments under <U>Section&nbsp;7.2(c)(i)</U>&nbsp;will be made on account of an involuntary
separation from service within the meaning of Treasury Regulation section 1.409A-1(n)(1)&nbsp;or a separation from service for
good reason within the meaning of Treasury Regulation section 1.409A-1(n)(2), (ii)&nbsp;amounts paid under <U>Section&nbsp;7.2(c)(i)</U>&nbsp;constitute
separation pay exempt from Internal Revenue Code Section&nbsp;409A under Treasury Regulation section 1.409A-1(b)(9)(iii), and (iii)&nbsp;Payments
under <U>Section&nbsp;7.2(c)(ii)</U>&nbsp;will be exempt from Code Section&nbsp;409A as a non-taxable fringe benefit to Executive,
but neither party will be liable to the other in the event any such payment receives different tax treatment. In the event any
of these payments is determined to be deferred compensation subject to Internal Revenue Code Section&nbsp;409A, the payments will
comply with <U>Section&nbsp;7.8</U>.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt"><B>6.3</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-variant: small-caps"><B><U>Termination Upon Death or Disability of Executive</U></B></FONT>.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 31.5pt"><FONT STYLE="font-size: 10pt"><B>a.</B></FONT></TD><TD STYLE="text-align: justify">Upon Executive&rsquo;s death while employed pursuant to this Agreement, this Agreement will automatically
terminate.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 31.5pt"><FONT STYLE="font-size: 10pt"><B>b.</B></FONT></TD><TD STYLE="text-align: justify">Subject to applicable state and federal law, the Company will at all times have the right, upon
thirty (30) days written notice to Executive, to terminate this Agreement based on Executive&rsquo;s Disability.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 31.5pt"><FONT STYLE="font-size: 10pt"><B>c.</B></FONT></TD><TD STYLE="text-align: justify">In the event Executive&rsquo;s employment is terminated due to Executive&rsquo;s death or Disability,
the Company will pay to Executive or Executive&rsquo;s heirs or estate all Standard Termination Payments together with any other
compensation and benefits payable to Executive through the Executive&rsquo;s Termination Date under any compensation or benefit
plan, program or arrangement during such period. In addition, if Executive, or if Executive is deceased, a participant on Executive&rsquo;s
health insurance plan, elects COBRA coverage, the Company will pay its third party administrator the full cost of COBRA coverage
for twelve (12) months from the Executive&rsquo;s Termination Date.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt"><B>6.4</B></FONT></TD><TD STYLE="text-align: justify"><B><U>Notice; Effective Date of Termination</U></B>.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt"><B>a.</B></FONT></TD><TD STYLE="text-align: justify">Termination of Executive&rsquo;s employment pursuant to this Agreement will be effective on the
earliest of:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 72pt"></TD><TD STYLE="width: 31.5pt"><FONT STYLE="font-size: 10pt"><B>(i)</B></FONT></TD><TD STYLE="text-align: justify">excluding a termination due to Executive&rsquo;s death or Disability, the date on which the Company
gives notice to Executive of Executive&rsquo;s termination, with or without Cause, unless the Company specifies a later date, in
which case, termination will be effective as of such later date;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 72pt"></TD><TD STYLE="width: 31.5pt"><FONT STYLE="font-size: 10pt"><B>(ii)</B></FONT></TD><TD STYLE="text-align: justify">the date of Executive&rsquo;s death;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 72pt"></TD><TD STYLE="width: 31.5pt"><FONT STYLE="font-size: 10pt"><B>(iii)</B></FONT></TD><TD STYLE="text-align: justify">ten (10)&nbsp;days after the Company gives notice to Executive of Executive&rsquo;s termination
on account of Executive&rsquo;s Disability; or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 72pt"></TD><TD STYLE="width: 31.5pt"><FONT STYLE="font-size: 10pt"><B>(iv)</B></FONT></TD><TD STYLE="text-align: justify">thirty (30) days after Executive gives written notice to the Company of Executive&rsquo;s resignation,
<I>provided </I>that the Company may set a termination date at any time between the date of notice and the 30<SUP>th</SUP> day
thereafter (<I>i.e.</I>, the effective date of resignation, but for this <U>Section&nbsp;7.5(a)</U>), in which case the Executive&rsquo;s
resignation will be effective as of such earlier date (the date on which Executive&rsquo;s resignation becomes effective, the &ldquo;<B><I>Actual
Resignation Effective Date</I></B>&rdquo;).</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt"><B>b.</B></FONT></TD><TD STYLE="text-align: justify">In the event that notice of a termination is given orally, at the other party&rsquo;s request,
the party giving notice must provide written confirmation of such notice within five (5)&nbsp;business days of the request. In
the event of a termination for Cause, written confirmation will specify the subsection(s)&nbsp;of the definition of Cause being
relied on by the Company to support the decision to terminate for Cause, to afford Executive a reasonable opportunity to effect
a cure, if permitted and possible under the applicable subsections of the definition of Cause. In the event of a resignation for
Good Reason, written confirmation will specify the subsection(s)&nbsp;of the definition of Good Reason being relied on by Executive
to support the decision to resign for Good Reason, to afford the Company a reasonable opportunity to cure under the applicable
subsections of the definition of Good Reason.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt"><B>6.5</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-variant: small-caps"><B><U>Cooperation With the Company After Termination of
Employment</U></B></FONT>. Notwithstanding anything to the contrary contained herein, payment of the amounts specified in this
Agreement is conditional upon Executive reasonably cooperating with the Company in connection with all matters relating to Executive&rsquo;s
employment with the Company, assisting the Company as reasonably requested in transitioning Executive&rsquo;s responsibilities
to Executive&rsquo;s replacement, and Executive being available to answer questions and provide transition assistance to the Company
through the end of the period during which Severance Benefits are to be paid. Following Executive&rsquo;s Termination Date, such
assistance will be provided at mutually acceptable times, and in reasonable amounts, taking into account other commitments that
Executive may have. Executive agrees to use Executive&rsquo;s best efforts to minimize any conflicts with other commitments to
facilitate this assistance. The Company agrees to reimburse Executive for reasonable out of pocket, pre-approved expenses incurred
in providing such assistance.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt; font-variant: small-caps"><B>6.6</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-variant: small-caps"><B><U>Application of Section&nbsp;280G</U></B>. </FONT>In
the event that it is determined that the Severance Benefit payable to Executive pursuant to <U>Section&nbsp;7</U> of this Agreement,
when added to any other payment or benefit to Executive from the Company that would be considered a &ldquo;parachute payment&rdquo;
(a &ldquo;<B><I>Parachute Payment</I></B>&rdquo;), within the meaning of section 280G of the Code, would cause Executive to be
considered to receive an &ldquo;excess parachute payment&rdquo; within the meaning of section 280G of the Code (an &ldquo;<B><I>Excess
Parachute Payment</I></B>&rdquo;), the amount payable to Executive pursuant to <U>Section&nbsp;7</U> of this Agreement will be
reduced to the maximum amount that, when added to any other Parachute Payments made to Executive, could be paid to Executive without
causing Executive to receive an Excess Parachute Payment. Notwithstanding the foregoing, the Severance Benefit payable to Executive
pursuant to <U>Section&nbsp;7</U> of this Agreement will not be reduced if (i)&nbsp;the net amount payable to Executive without
the reduction described in the preceding sentence, but reduced by all Federal, state and local income and employment taxes payable
by Executive on the Severance Benefit payable pursuant to this Agreement and all other Parachute Payments plus the excise tax payable
on the Excess Parachute Payment pursuant to Section&nbsp;4999 of the Code, is greater than (ii)&nbsp;the net amount that would
be payable to Executive with the reduction described in the preceding sentence and reduced by all Federal, state and local income
and employment taxes payable by Executive on the Severance Benefit payable pursuant to this Agreement and all other Parachute Payments.
For purposes of this <U>Section&nbsp;7.7</U>, Executive will be deemed to pay Federal income tax and employment taxes at the highest
marginal rate of Federal income and employment taxation in the calendar year in which the Excess Parachute Payment would occur
and state and local income taxes at the highest marginal rate of taxation in the state and locality of Executive&rsquo;s residence
in the calendar year in which the Excess Parachute Payment would be made, net of the reduction in Federal income taxes that Executive
may obtain from the deduction of such state and local income taxes. In addition, all determinations to be made under this <U>Section&nbsp;7.7</U>
will be made by the Company&rsquo;s independent public accountant (the &ldquo;<B><I>Accounting Firm</I></B>&rdquo;) immediately
before the date the Severance Benefit under <U>Section&nbsp;7</U> is to be paid. The Accounting Firm will provide its determinations
and any supporting calculations and work papers both to the Company and to Executive within ten (10)&nbsp;days of such date, and
any such determination by the Accounting Firm will be binding upon the Company and Executive.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt"><B>6.7</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-variant: small-caps"><B><U>Deferred Compensation Subject to Code Section&nbsp;409A</U></B></FONT>.
Notwithstanding anything to the contrary set forth herein, any payments and benefits provided under this Agreement that constitute
 &ldquo;deferred compensation&rdquo; within the meaning of Code Section&nbsp;409A will not commence in connection with Executive&rsquo;s
termination of employment unless and until Executive has also incurred a &ldquo;separation from service&rdquo; (as such term is
defined in Treasury Regulation Section&nbsp;1.409A-1(h)&nbsp;(&ldquo;<B><I>Separation From Service</I></B>&rdquo;), unless the
Company reasonably determines that such amounts may be provided to Executive without causing Executive to incur additional tax
under Code Section&nbsp;409A. It is intended that each installment of Severance Benefits provided for in this Agreement is a separate
 &ldquo;payment&rdquo; for purposes of Treasury Regulation Section&nbsp;1.409A-2(b)(2)(i). For the avoidance of doubt, it is intended
that Severance Benefits set forth in this Agreement satisfy, to the greatest extent possible, the exceptions from the application
of Section&nbsp;409A provided under Treasury Regulation Sections 1.409A-1(b)(4), 1.409A-1(b)(5), and 1.409A-1(b)(9). If the Company
(or, if applicable, the successor entity thereto) determines that any payments or benefits constitute &ldquo;deferred compensation&rdquo;
under Code Section&nbsp;409A and Executive is, on the termination of service, a &ldquo;specified Executive&rdquo; of the Company
or any successor entity thereto, as such term is defined in Section&nbsp;409A(a)(2)(B)(i)&nbsp;of the Code, then, solely to the
extent necessary to avoid the incurrence of the adverse personal tax consequences to Executive under Section&nbsp;409A, the timing
of the payments and benefits will be delayed until the earlier to occur of: (a)&nbsp;the date that is six (6)&nbsp;months and one
day after Executive&rsquo;s Separation From Service, or (b)&nbsp;the date of Executive&rsquo;s death (such applicable date, the
 &ldquo;<B><I>Specified Executive Initial Payment Date</I></B>&rdquo;). On the Specified Executive Initial Payment Date, the Company
(or the successor entity thereto, as applicable) will (i)&nbsp;pay to Executive a lump sum amount equal to the sum of the payments
and benefits that Executive would otherwise have received through the Specified Executive Initial Payment Date if the commencement
of the payment of such amounts had not been so delayed pursuant to this <U>Section&nbsp;7.8</U> and (ii)&nbsp;commence paying the
balance of the payments and benefits in accordance with the applicable payment schedules set forth in this Agreement.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt"><B>7.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-variant: small-caps"><B><U>General Provisions</U></B></FONT>.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt"><B>7.1</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-variant: small-caps"><B><U>Notices</U></B></FONT>. Any notice required or permitted
under this Agreement will be given in writing by delivery in hand, express courier or by postage prepaid, United States first class
mail; registered or certified mail, return receipt requested; facsimile at the party&rsquo;s specified address; or as otherwise
specified by a party. Notice will be effective upon receipt.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt"><B>7.2</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-variant: small-caps"><B><U>Right To Injunctive Relief</U></B></FONT>. Executive
agrees and acknowledges that a violation of the covenants contained in <U>Section&nbsp;4</U> of this Agreement will cause irreparable
damage to the Company, and that it is and will be impossible to estimate or determine the damage that will be suffered by the Company
in the event of breach by Executive of any such covenant. Therefore, Executive further agrees that, in the event of any violation
or threatened violation of such covenants, the Company will be entitled to an injunction issued by any court of competent jurisdiction
restraining such violation or threatened violation by Executive, such right to an injunction to be cumulative and in addition to
whatever other remedies the Company may have.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt"><B>7.3</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-variant: small-caps"><B><U>Partial Invalidity/Severability/No Amendment Of Existing
Agreements</U></B>. </FONT>Executive acknowledges that the periods of time and geographic area of restrictions imposed by <U>Section&nbsp;4</U>
are fair and reasonable and are reasonably required for the protection of the Company. If any part or parts of <U>Section&nbsp;4</U>
will be held to be unenforceable or invalid, the remaining parts thereof will nevertheless continue to be valid and enforceable
as though the invalid portion or portions were not a part hereof. If any of the provisions of <U>Section&nbsp;4</U> relating to
the scope of restrictions, periods of time or geographic area of restriction will be deemed to exceed the scope of restrictions,
maximum periods of time or area which a court of competent jurisdiction would deem enforceable, the scope of restrictions, time
and area will, for purposes of <U>Section&nbsp;4</U>, be deemed to be the maximum scope, time periods and area which a court of
competent jurisdiction would deem valid and enforceable. If any other paragraph or subparagraph of this Agreement will be unenforceable
under any applicable law, the remainder of this Agreement will remain in full force and effect. Except as specifically provided
herein, nothing in this Agreement is intended to modify any existing agreements between the Company and Executive with regard to
the matters in <U>Section&nbsp;4</U>.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt"><B>7.4</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-variant: small-caps"><B><U>Waiver</U></B></FONT>. If either party should waive
any breach of any provisions of this Agreement, such party will not thereby be deemed to have waived any preceding or succeeding
breach of the same or any other provision of this Agreement. It is agreed that no delay or omission to exercise any right, power
or remedy accruing to either party, upon any breach, default or noncompliance by the other party under this Agreement will impair
any such right, power or remedy, nor will it be construed to be a waiver of any such breach, default or noncompliance, or any acquiescence
therein, or of or in any similar breach, default or noncompliance thereafter occurring. It is further agreed that any waiver, permit,
consent or approval of any kind or character on either party&rsquo;s part of any breach, default or noncompliance under this Agreement
or any waiver on such party&rsquo;s part of any provisions or conditions of the Agreement must be in writing and will be effective
only to the extent specifically set forth in such writing. All remedies, either under this Agreement by law, or otherwise afforded
to either party, will be cumulative and not alternative.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt"><B>7.5</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-variant: small-caps"><B><U>Withholding</U></B></FONT>. All amounts payable hereunder
will be reduced by any and all federal, state, and local taxes imposed upon the Executive that are required to be paid or withheld
by the Company.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt"><B>7.6</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-variant: small-caps"><B><U>Complete Agreement</U></B></FONT>. This Agreement,
your offer letter and the Confidentiality and Non-Compete Agreement constitute the entire agreement between Executive and the Company
with regard to the subject matter hereof. These agreements are the complete, final, and exclusive embodiment of the parties&rsquo;
agreement with regard to this subject matter and supersede any prior oral discussions or written communications and agreements,
including but not limited to any previous agreements. In the event of a conflict between this Agreement, the offer letter or the
Confidentiality and Non-Compete Agreement, the provisions of this Agreement will control. This Agreement is entered into without
reliance on any promise or representation other than those expressly contained herein, and it cannot be modified or amended except
in writing signed by Executive and an authorized officer of the Company. The parties may enter into separate agreement(s)&nbsp;related
to stock options, stock awards or other matters relative to Executive&rsquo;s service with the Company or its affiliates. These
separate agreements govern (or may govern) other aspects of the relationship between the parties, have or may have provisions that
survive termination of Executive&rsquo;s employment under this Agreement, may be amended or superseded by the parties without regard
to this Agreement and are enforceable according to their terms without regard to the enforcement provision of this Agreement.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt"><B>7.7</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-variant: small-caps"><B><U>Counterparts</U></B></FONT>. This Agreement may be
executed in separate counterparts, including facsimile, PDF, or other electronic counterparts, any one of which need not contain
signatures of more than one party, but all of which taken together will constitute one and the same Agreement.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt"><B>7.8</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-variant: small-caps"><B><U>Headings</U></B></FONT>. The headings of the sections
hereof are inserted for convenience only and will not be deemed to constitute a part hereof nor to affect the meaning thereof.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt"><B>7.9</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-variant: small-caps"><B><U>Successors and Assigns</U></B></FONT>. The Company
may assign this Agreement and its rights and obligations hereunder in whole, but not in part, to any company or other entity with
or into which the Company may hereafter merge, consolidate, or be acquired by, or to which the Company may transfer all or substantially
all of its assets. Executive may not assign or transfer this Agreement or any rights or obligations hereunder, other than to Executive&rsquo;s
estate upon Executive&rsquo;s death.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt"><B>7.10</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-variant: small-caps"><B><U>Choice of Law / Venue</U></B></FONT>. All questions
concerning the construction, validity and interpretation of this Agreement will be governed by the internal, substantive laws of
the State of Colorado, as applied to agreements made and to be performed solely within the State of Colorado and without regard
to the principles of conflicts of laws of the State of Colorado or of any other jurisdiction that would result in the application
of the laws of any other jurisdiction to this Agreement. Any action brought to enforce this Agreement will be brought in Colorado
in a court of competent jurisdiction.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt"><B>7.11</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-variant: small-caps"><B><U>Attorneys&rsquo; Fees</U></B></FONT><B>.</B> In any
action brought to enforce this Agreement, the substantially prevailing party in such dispute will be entitled to recover from the
losing party all reasonable fees, costs and expenses of enforcing any right of such substantially prevailing party under or with
respect to this Agreement, including without limitation, such reasonable fees and expenses of attorneys, which will include, without
limitation, all fees, costs and expenses of appeal.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt; font-variant: small-caps"><B>In
Witness Whereof</B></FONT>, the parties have executed this Agreement on the day and year first written above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Company:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-variant: small-caps"><B>Zynex,&nbsp;Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 4%; text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By: </FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 46%; text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/Thomas Sandgaard</FONT></TD>
    <TD STYLE="width: 50%; text-align: justify; font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="3" STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:&nbsp;&nbsp;President&nbsp;&amp; CEO</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Executive: Anna Lucsok</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid; width: 50%; text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Anna Lucsok</FONT></TD>
    <TD STYLE="width: 50%; text-align: justify; font-size: 10pt">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: bottom">
    <TD COLSPAN="3" STYLE="font: 10pt Times New Roman, Times, Serif"></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[Signature Page&nbsp;to Employment Agreement]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 10; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>3
<FILENAME>tm214568d1_ex99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit&nbsp;99.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Zynex Appoints Anna Lucsok as Chief Operating
Officer of Zynex Medical</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">ENGLEWOOD,&nbsp;Colo., (PR Newswire, &nbsp;January&nbsp;28,
2021) --&nbsp;Zynex,&nbsp;Inc.&nbsp;(NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and
sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics
today announced that it has promoted Anna Lucsok to Chief Operating Officer (COO) of Zynex Medical, its pain management division.
Joseph Papandrea, previously held the position of COO.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Thomas Sandgaard, founder and CEO said:
 &ldquo;I would personally like to thank Joseph for his leadership and contributions. We wish him nothing but the best in the future.
I would also like to congratulate Anna on a well-deserved promotion to COO of Zynex Medical. Anna has been instrumental in transforming
our reimbursement and sales operations, which are the backbone of the Company, along with our expansions to elevate our patient&rsquo;s
experience.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Anna Lucsok previously served as Vice President of Reimbursement
and Sales Operations with Zynex Medical. In this position she was responsible for leading and expanding Zynex&rsquo;s order, reimbursement,
patient experience, and inside sales support operations. During her tenure each of these teams have consistently achieved quarterly
targets, while also expanding in size. Ms.&nbsp;Lucsok brings more than 9 years of healthcare operations experience as well as
critical knowledge of revenue cycle management and medical care collections. Ms.&nbsp;Lucsok has been involved in various operations
positions as well as management positions with Zynex since her start in 2018, including serving as Billing Manager and Analyst.
She&rsquo;s previously held key positions with companies such as University of Colorado Hospital, the US Air Force based in Germany
and Japan, and Schryver Medical. Ms.&nbsp;Lucsok holds certification in medical billing as well as completed her degree in Healthcare
Administration and Management from Colorado State University.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Ms.&nbsp;Lucsok added, &ldquo;I&rsquo;m honored to take on this
new role with the Company and I too, want to thank Joseph for his contributions in setting the stage for our plans as we continue
to scale seamlessly in 2021 and beyond. I&rsquo;m excited about the opportunities in front of us as our internal and sales teams
continue to drive our growth and success, while focusing on providing exceptional patient care.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="background-color: white"><B>About Zynex</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt; background-color: white">Zynex,
founded in 1996, markets and sells its own design of electrotherapy medical devices used for pain management and rehabilitation;
and the Company's proprietary NeuroMove device designed to help recovery of stroke and spinal cord injury patients. Zynex has also
developed a blood volume monitor for use in hospitals and surgery centers.&nbsp; For additional information, please visit:&nbsp;</FONT>Zynex.com.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Safe Harbor Statement</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #222222"><FONT STYLE="background-color: white">This release
contains forward-looking statements within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation
Reform Act of 1995.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt; color: #252525">Forward</FONT><FONT STYLE="color: #252525; background-color: white">-</FONT><FONT STYLE="color: #252525">looking<FONT STYLE="background-color: white">&nbsp;statements
are neither historical facts nor assurances of future performance. Instead, they are based only on our current beliefs, expectations
and assumptions regarding the future of our business, future plans and strategies, projections, forecasts, anticipated events and
trends, the economy and other future conditions. Because&nbsp;</FONT>forward<FONT STYLE="background-color: white">-</FONT>looking<FONT STYLE="background-color: white">&nbsp;statements
relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict
and many of which are outside of our control. Our actual results and financial condition may differ materially from those indicated
in the forward-looking statements. Therefore you should not rely on any of these forward looking statements. </FONT></FONT> <FONT STYLE="background-color: white">The
Company makes no express or implied representation or warranty as to the completeness of forward looking statements or, in the
case of projections, as to their attainability or the accuracy and completeness of the assumptions from which they are derived.
Factors that could cause actual results to materially differ from forward-looking statements include, but are not limited to, the
need to obtain CE marking of new products, the acceptance of new products as well as existing products by doctors and hospitals,
larger competitors with greater financial resources, the need to keep pace with technological changes, our dependence on the reimbursement
for our products from health insurance companies, our dependence on third party manufacturers to produce our goods on time and
to our specifications, implementation of our sales strategy including a strong direct sales force, the impact of COVID-19 on the
global economy and other risks described in our filings with the Securities and Exchange Commission including but not limited to
our Annual Report on Form&nbsp;10-K for the year ended&nbsp;December&nbsp;31, 2019&nbsp;as well as our quarterly reports on Form&nbsp;10-Q
and current reports on Form&nbsp;8-K.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="background-color: white">Any forward-looking statement
made by us in this release is based only on information currently available to us and speaks only as of the date on which it is
made. We undertake no obligation to publicly update any forward-looking statement, whether written or oral, that may be made from
time to time, whether as a result of new information, future developments or otherwise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="background-color: white"><B>Contact:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="background-color: white">Zynex,&nbsp;Inc.<BR>
(800) 495-6670</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt; background-color: white"><B>Investor
Relations Contact:</B><BR>
Amato and Partners, LLC<BR>
Investor Relations Counsel<BR>
</FONT><FONT STYLE="color: Black; background-color: white">admin@amatoandpartners.com</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>zyxi-20210127.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.6a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: +K85w7xRiXgen8uNbXAsWa6NmbPtzp5xCekhuWh7bWl6TyotytXVXiAkT1N2Qc4E -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31" xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31" xmlns:srt="http://fasb.org/srt/2020-01-31" xmlns:srt-types="http://fasb.org/srt-types/2020-01-31" xmlns:zyxi="http://zynexmed.com/20210127" elementFormDefault="qualified" targetNamespace="http://zynexmed.com/20210127">
    <annotation>
      <appinfo>
	<link:roleType roleURI="http://zynexmed.com/role/Cover" id="Cover">
	  <link:definition>00000001 - Document - Cover</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:linkbaseRef xlink:type="simple" xlink:href="zyxi-20210127_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="zyxi-20210127_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2020-01-31" schemaLocation="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd" />
    <import namespace="http://fasb.org/us-gaap/2020-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd" />
    <import namespace="http://fasb.org/us-types/2020-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2020-01-31" schemaLocation="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd" />
    <import namespace="http://fasb.org/srt/2020-01-31" schemaLocation="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd" />
    <import namespace="http://fasb.org/srt-types/2020-01-31" schemaLocation="http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>zyxi-20210127_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.6a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>zyxi-20210127_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.6a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://zynexmed.com/role/Cover" xlink:href="zyxi-20210127.xsd#Cover" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://zynexmed.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>tm214568d1_ex10-1img01.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm214568d1_ex10-1img01.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  (! 0(! 0(" @(" @(" P4# P,#
M P8$! ,%!P8'!P<&!P<("0L)" @*" <'"@T*"@L,# P,!PD.#PT,#@L,# S_
MVP!# 0(" @,# P8# P8," <(# P,# P,# P,# P,# P,# P,# P,# P,# P,
M# P,# P,# P,# P,# P,# P,# P,# S_P  1" !H ,0# 2(  A$! Q$!_\0
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M;'U^U64D7_H2BOZ8%^#JA0-B<=/D'%9FN_LW:-XAB*W^C:1?@C!%S8Q3 _\
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MBV_X+G>'_P!I[]@#3_%FFK-H=_);-%XLA^[]BG0 -;0OT82GD,.B$]Q7S/\
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MXO%/BN_TRY@NK72[W6YVTF'RL;8Q:AO+\LD99<88LV<Y-?07A;P>?.5G0*B
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M*>7Q<Y:U7T[>OF>;6A+$OE6D%^)YO_P2_P#^"86E?L6^$))[J2'7/'VNHO\
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M=O:VL0BAA4= JC@"NLTG0(=,C&%&X=ZNQQB)<*,4ZL2PHHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
%BB@#_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>tm214568d1_8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="zyxi-20210127.xsd" xlink:type="simple"/>
    <context id="From2021-01-27to2021-01-27">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000846475</identifier>
        </entity>
        <period>
            <startDate>2021-01-27</startDate>
            <endDate>2021-01-27</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:EntityCentralIndexKey contextRef="From2021-01-27to2021-01-27">0000846475</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="From2021-01-27to2021-01-27">false</dei:AmendmentFlag>
    <dei:DocumentType contextRef="From2021-01-27to2021-01-27">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="From2021-01-27to2021-01-27">2021-01-27</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="From2021-01-27to2021-01-27">Zynex, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="From2021-01-27to2021-01-27">NV</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="From2021-01-27to2021-01-27">001-38804</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="From2021-01-27to2021-01-27">90-0275169</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="From2021-01-27to2021-01-27">9555 Maroon Circle</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="From2021-01-27to2021-01-27">Englewood</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="From2021-01-27to2021-01-27">CO</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="From2021-01-27to2021-01-27">80112</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="From2021-01-27to2021-01-27">303</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="From2021-01-27to2021-01-27">703-4906</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="From2021-01-27to2021-01-27">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="From2021-01-27to2021-01-27">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="From2021-01-27to2021-01-27">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="From2021-01-27to2021-01-27">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="From2021-01-27to2021-01-27">Common Stock, $0.001 par value per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2021-01-27to2021-01-27">ZYXI</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2021-01-27to2021-01-27">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="From2021-01-27to2021-01-27">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140087798531272">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Jan. 27, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jan. 27,  2021<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-38804<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Zynex,
Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000846475<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">90-0275169<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">NV<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">9555 Maroon Circle<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Englewood<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CO<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">80112<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">303<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">703-4906<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $0.001 par value per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">ZYXI<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>10
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M%_\;SO$1PNZ_/[&\UDX:?^:+X3]>?P%02P$"% ,4    " #]@SQ2!T%-8H$
M  "Q    $               @ $     9&]C4')O<',O87!P+GAM;%!+ 0(4
M Q0    ( /V#/%*)YR.V[@   "L"   1              "  :\   !D;V-0
M<F]P<R]C;W)E+GAM;%!+ 0(4 Q0    ( /V#/%*97)PC$ 8  )PG   3
M          "  <P!  !X;"]T:&5M92]T:&5M93$N>&UL4$L! A0#%     @
M_8,\4C$) $XL!   )Q   !@              ("!#0@  'AL+W=O<FMS:&5E
M=',O<VAE970Q+GAM;%!+ 0(4 Q0    ( /V#/%*#J:4#U $  #(&   -
M          "  6\,  !X;"]S='EL97,N>&UL4$L! A0#%     @ _8,\4I>*
MNQS     $P(   L              ( !;@X  %]R96QS+RYR96QS4$L! A0#
M%     @ _8,\4JK$(A8S 0  (@(   \              ( !5P\  'AL+W=O
M<FMB;V]K+GAM;%!+ 0(4 Q0    ( /V#/%(D'INBK0   /@!   :
M      "  ;<0  !X;"]?<F5L<R]W;W)K8F]O:RYX;6PN<F5L<U!+ 0(4 Q0
M   ( /V#/%)ED'F2&0$  ,\#   3              "  9P1  !;0V]N=&5N
B=%]4>7!E<UTN>&UL4$L%!@     )  D /@(  .82      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.20.4</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>96</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="tm214568d1_8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://zynexmed.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="tm214568d1_8k.htm">tm214568d1_8k.htm</File>
    <File>tm214568d1_ex10-1.htm</File>
    <File>tm214568d1_ex99-1.htm</File>
    <File>zyxi-20210127.xsd</File>
    <File>zyxi-20210127_lab.xml</File>
    <File>zyxi-20210127_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2020-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>15
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "tm214568d1_8k.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "definitionLink": {
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-eedm-def-2020-01-31.xml",
      "http://xbrl.fasb.org/srt/2020/elts/srt-eedm1-def-2020-01-31.xml"
     ]
    },
    "inline": {
     "local": [
      "tm214568d1_8k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "zyxi-20210127_lab.xml"
     ],
     "remote": [
      "https://xbrl.sec.gov/dei/2020/dei-doc-2020-01-31.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "zyxi-20210127_pre.xml"
     ]
    },
    "referenceLink": {
     "remote": [
      "https://xbrl.sec.gov/dei/2020/dei-ref-2020-01-31.xml"
     ]
    },
    "schema": {
     "local": [
      "zyxi-20210127.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-roles-2020-01-31.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-roles-2020-01-31.xsd",
      "https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd",
      "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd"
     ]
    }
   },
   "elementCount": 59,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2020-01-31": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 96,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "zyxi",
   "nsuri": "http://zynexmed.com/20210127",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "baseRef": "tm214568d1_8k.htm",
      "contextRef": "From2021-01-27to2021-01-27",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "00000001 - Document - Cover",
     "role": "http://zynexmed.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "baseRef": "tm214568d1_8k.htm",
      "contextRef": "From2021-01-27to2021-01-27",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of changes contained within amended document.",
        "label": "Amendment Description"
       }
      }
     },
     "localname": "AmendmentDescription",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://zynexmed.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://zynexmed.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AnnualInformationForm": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.",
        "label": "Annual Information Form"
       }
      }
     },
     "localname": "AnnualInformationForm",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://zynexmed.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditedAnnualFinancialStatements": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.",
        "label": "Audited Annual Financial Statements"
       }
      }
     },
     "localname": "AuditedAnnualFinancialStatements",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://zynexmed.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://zynexmed.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CountryRegion": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Region code of country",
        "label": "Country Region"
       }
      }
     },
     "localname": "CountryRegion",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://zynexmed.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://zynexmed.com/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAccountingStandard": {
     "auth_ref": [
      "r11"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.",
        "label": "Document Accounting Standard"
       }
      }
     },
     "localname": "DocumentAccountingStandard",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://zynexmed.com/role/Cover"
     ],
     "xbrltype": "accountingStandardItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r9",
      "r11",
      "r12"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://zynexmed.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://zynexmed.com/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://zynexmed.com/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://zynexmed.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentPeriodStartDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.",
        "label": "Document Period Start Date"
       }
      }
     },
     "localname": "DocumentPeriodStartDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://zynexmed.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r10"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://zynexmed.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentRegistrationStatement": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a registration statement.",
        "label": "Document Registration Statement"
       }
      }
     },
     "localname": "DocumentRegistrationStatement",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://zynexmed.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentShellCompanyEventDate": {
     "auth_ref": [
      "r11"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date of event requiring a shell company report.",
        "label": "Document Shell Company Event Date"
       }
      }
     },
     "localname": "DocumentShellCompanyEventDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://zynexmed.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentShellCompanyReport": {
     "auth_ref": [
      "r11"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.",
        "label": "Document Shell Company Report"
       }
      }
     },
     "localname": "DocumentShellCompanyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://zynexmed.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://zynexmed.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://zynexmed.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://zynexmed.com/role/Cover"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://zynexmed.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://zynexmed.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine3": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 3 such as an Office Park",
        "label": "Entity Address, Address Line Three"
       }
      }
     },
     "localname": "EntityAddressAddressLine3",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://zynexmed.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://zynexmed.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://zynexmed.com/role/Cover"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://zynexmed.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://zynexmed.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.",
        "label": "Entity Bankruptcy Proceedings, Reporting Current"
       }
      }
     },
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://zynexmed.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://zynexmed.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://zynexmed.com/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://zynexmed.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://zynexmed.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r17"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Elected Not To Use the Extended Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://zynexmed.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://zynexmed.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://zynexmed.com/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://zynexmed.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://zynexmed.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPrimarySicNumber": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.",
        "label": "Entity Primary SIC Number"
       }
      }
     },
     "localname": "EntityPrimarySicNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://zynexmed.com/role/Cover"
     ],
     "xbrltype": "sicNumberItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://zynexmed.com/role/Cover"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://zynexmed.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://zynexmed.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://zynexmed.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://zynexmed.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://zynexmed.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://zynexmed.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_Extension": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Extension number for local phone number.",
        "label": "Extension"
       }
      }
     },
     "localname": "Extension",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://zynexmed.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://zynexmed.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_NoTradingSymbolFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a security having no trading symbol.",
        "label": "No Trading Symbol Flag"
       }
      }
     },
     "localname": "NoTradingSymbolFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://zynexmed.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_OtherReportingStandardItemNumber": {
     "auth_ref": [
      "r11"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.",
        "label": "Other Reporting Standard Item Number"
       }
      }
     },
     "localname": "OtherReportingStandardItemNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://zynexmed.com/role/Cover"
     ],
     "xbrltype": "otherReportingStandardItemNumberItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://zynexmed.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://zynexmed.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://zynexmed.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_Security12gTitle": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(g) registered security.",
        "label": "Title of 12(g) Security"
       }
      }
     },
     "localname": "Security12gTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://zynexmed.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://zynexmed.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SecurityReportingObligation": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.",
        "label": "Security Reporting Obligation"
       }
      }
     },
     "localname": "SecurityReportingObligation",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://zynexmed.com/role/Cover"
     ],
     "xbrltype": "securityReportingObligationItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r8"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://zynexmed.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://zynexmed.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r16"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://zynexmed.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 3
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r10": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a"
  },
  "r11": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f"
  },
  "r12": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f"
  },
  "r13": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r14": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r15": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r16": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  },
  "r17": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2"
  },
  "r18": {
   "Name": "Securities Act",
   "Number": "Section",
   "Publisher": "SEC",
   "Section": "12"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "g"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12, 13, 15d"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r6": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r7": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "15",
   "Subsection": "d"
  },
  "r8": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r9": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>16
<FILENAME>0001104659-21-008810-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001104659-21-008810-xbrl.zip
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MO?V*1S-[<Q8"KO- R( Z/O%=&&AB9$P*)>(*4JBL6*O$[1"_QT 9F1D([G/
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M@QV4C8NF5;F(KLKJ?4!&-Z(1CR#V][H4 5KC7%,;2Y61 - 6^-?1SEJ[):/
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M6FDJ3V7C;/?W\K)V32CR+EJXVU3CYF)YJUK,EY(]#\/2:: 2K2]849LR9/U
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M]_3U\W\2I?YR\>NKL_\!4$L#!!0    ( /V#/%)_(D4W%0P  'DF   5
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M5*'?JUPN&]QC76V5SJ&FK(2IQ!S0*;U;N I?=B%5N?N0$BVBGI],)B\^PM4
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MD3BMF0;G2+1*6Z)>+8&3"(L L&BY", BF%>1K@%W57 4;C*:7/4+R@9J;=&
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M=G6?W;SU"_0V_.]/;QVEV#T,!]$IZS"#N-!,6VV(!:E3H%4+L2 M=P+&:Q!
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M)/!VLV_MS+MM.M V_5::0M+O *"M.O6=)<(5XH-R51%S_OW%ID)H*D&[/%*
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MFKG=B,-E.E+"O^&ETA#+F20Y#$@C0;WC337D/1,L7I*LL%(.Z2AQM8BG3$[
MOXZBVA*+F21+#(DC'I,GJ#%Y\L0QF21;](DB)5RN<+??L9N1X!/FWRT7+(#>
M/T3)/2"59J=BL:')[6/7:>%-WWZHAN\QQ6*GV1(:DD<#/$^X@:1TK,\ED[%-
MQS8[^#SY?7TI;!AH]HPB11-.(GP%(3Y(-9=#8)F2D)0)0F@>P5L$&PO"N<L:
MN82!^*)$;EGI8O&J]GP?/*98\(1SEAYYE"M%RT79FRM3^2*3$'=?"2Q^PLG+
ML%C2%70&G.?\$=XQPU9^AJ+@*X&- N%$9E@L\2X W;.7I8D*S]OO&6*9$R[?
MK91&B'J8,B$N\XQ+R(*CS9XA%C7A.MU*:82HKU+0$SO8O==J;J:K':TAY)X"
M6/2$JW&#4BE#L/BYG[[<Z1?D7V&-?E<#(7RO2-H7DL2Q6]A17NUEPK2'?<@>
M2Y]T(ZE?* G_&S,%O7VG5;@TL#E?:/E%?2EL+$A27:QHRBOOUGL-@A?>'3LL
M=<*DMDH8Y8ZP?"1XW!>*!>_C=\RPE DSV I9A) OF7S0^<S$RUNM8@ W59-M
MOG^(- I9 38PA+GMDU!0/G!0:>JV2JGX83BUTK.;W!3OA;5>!A\[!,MA T2Y
M:14AG/1.*?NYF0V2R^4=C$&[!1/WL#"7MKF'\(T3HC@V2J1O7T)CJ C66>M
MU[4]X-X 7)YQO]Q;;NV1'U!+ 0(4 Q0    ( /V#/%)%^49[V1<  'J!   1
M              "  0    !T;3(Q-#4V.&0Q7SAK+FAT;5!+ 0(4 Q0    (
M /V#/%+XL'[XE#8  )5$ 0 5              "  0@8  !T;3(Q-#4V.&0Q
M7V5X,3 M,2YH=&U02P$"% ,4    " #]@SQ2?R)%-Q4,  !Y)@  %0
M        @ '/3@  =&TR,30U-CAD,5]E>#DY+3$N:'1M4$L! A0#%     @
M_8,\4ONZL.Y  P  D P  !$              ( !%UL  'IY>&DM,C R,3 Q
M,C<N>'-D4$L! A0#%     @ _8,\4I56":S^"@  X(<  !4
M ( !AEX  'IY>&DM,C R,3 Q,C=?;&%B+GAM;%!+ 0(4 Q0    ( /V#/%*O
M^G/L6@<  #59   5              "  ;=I  !Z>7AI+3(P,C$P,3(W7W!R
;92YX;6Q02P4&      8 !@"* 0  1'$

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
